financetom
Business
financetom
/
Business
/
Teladoc Health to Acquire Catapult Health for $65 Million Plus Up to $5 Million In Additional Earnout
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Teladoc Health to Acquire Catapult Health for $65 Million Plus Up to $5 Million In Additional Earnout
Feb 5, 2025 6:01 AM

08:44 AM EST, 02/05/2025 (MT Newswires) -- Teladoc Health ( TDOC ) said Wednesday it agreed to acquire Catapult Health for $65 million in cash and up to $5 million in additional contingent earnouts.

The deal is expected to close in Q1, at which point Catapult will become part of Teladoc's integrated care division, the company said.

Teladoc said the acquisition supports its efforts to grow membership, broaden services, expand internationally, and advance its scaled mental health offerings.

TDOC shares were 0.4% higher in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
KKR Completes Acquisition of OSTTRA From S&P Global and CME Group
KKR Completes Acquisition of OSTTRA From S&P Global and CME Group
Oct 10, 2025
NEW YORK--(BUSINESS WIRE)-- KKR, a leading global investment firm, today announced that investment funds managed by KKR have completed the acquisition of OSTTRA, a leading provider of post-trade solutions for the global OTC market, from S&P Global and CME Group. The terms of the deal for OSTTRA equaled total enterprise value at $3.1 billion. Established in 2021 as a joint...
Serve Robotics Announces $100 Million Registered Direct Offering of Common Stock
Serve Robotics Announces $100 Million Registered Direct Offering of Common Stock
Oct 10, 2025
SAN FRANCISCO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Serve Robotics Inc. ( SERV ) (Serve or the Company) , a leading autonomous sidewalk delivery company, announced today that the Company has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 6,250,000 shares of common stock, pursuant to a registered direct offering, expected to result...
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
Oct 10, 2025
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases Transaction further strengthens BMS’s industry-leading cell therapy portfolio, expanding CAR T-cell access to more patients in the future PRINCETON, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Bristol Myers Squibb ( BMY ) and Orbital Therapeutics (“Orbital”) today announced a...
S&P Global and CME Group Complete Sale of OSTTRA to KKR
S&P Global and CME Group Complete Sale of OSTTRA to KKR
Oct 10, 2025
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- S&P Global ( SPGI ) and CME Group today announced that they have completed the sale of OSTTRA to KKR, a leading global investment firm. The terms of the deal for OSTTRA equaled total enterprise value at $3.1 billion, which will be divided evenly between S&P Global ( SPGI ) and CME Group...
Copyright 2023-2026 - www.financetom.com All Rights Reserved